Last update 26 Jun 2026

SNA02-48

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
SNA02-48
Target-
Action-
Mechanism-
Therapeutic Areas
Infectious DiseasesOther Diseases
Active Indication
Tetanus
Inactive Indication-
Originator Organization
Beijing Kexing Zhongwei Biotechnology Co. Ltd.Beijing Kexing Zhongwei Biotechnology Co. Ltd.
Active Organization
Synermore Biologics (Suzhou) Co., Ltd.Synermore Biologics (Suzhou) Co., Ltd.Beijing Kexing Zhongwei Biotechnology Co. Ltd.Beijing Kexing Zhongwei Biotechnology Co. Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with SNA02-48
NCT07633119
/ Not yet recruitingPhase 3
A Multicenter, Randomized, Double-Blind, Active-Controlled Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of SNA02-48 Injection in Populations With High-Risk Tetanus Exposure
NCT06939777
/ CompletedPhase 1/2
A Randomized, Double-Blind, Controlled, Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SNA02-48 Injection in Chinese Adult Participants
100 Clinical Results associated with SNA02-48
Login to view more data
100 Translational Medicine associated with SNA02-48
Login to view more data
100 Patents (Medical) associated with SNA02-48
Login to view more data
100 Deals associated with SNA02-48
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
TetanusPhase 3
China
Beijing Kexing Zhongwei Biotechnology Co. Ltd.Beijing Kexing Zhongwei Biotechnology Co. Ltd.
28 Jun 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free